VEA
EW icon

Virtus ETF Advisers’s Edwards Lifesciences EW Stock Holding History

Virtus ETF Advisers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,536
Closed -$881K – 467
2024
Q2 		$881K Buy
+9,536
New +$844K 0.43% 85
2022
Q4 		– Sell
-6,548
Closed -$541K – 457
2022
Q3 		$541K Buy
6,548
+559
+9% +$53.8K 0.22% 203
2022
Q2 		$569K Buy
+5,989
New +$620K 0.21% 212
2019
Q4 		– Sell
-348
Closed -$26K – 475
2019
Q3 		$26K Buy
+348
New +$24.4K 0.01% 325

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Virtus ETF Advisers's EW Position: Q3 2024 in Review

Virtus ETF Advisers sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 9,536 shares — an estimated $881K sold.

Virtus ETF Advisers first reported a position in EW in Q3 2019 and held it in 4 quarters. The position peaked at $881K in Q2 2024. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Virtus ETF Advisers reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 9,536 Edwards Lifesciences shares in Q3 2024, an estimated $881K.
  • Virtus ETF Advisers first reported a position in Edwards Lifesciences in Q3 2019 and held it in 4 quarters.
  • Virtus ETF Advisers's Edwards Lifesciences position peaked at $881K in Q2 2024.
  • 1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Virtus ETF Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.